N

Nanovation Therapeutics

Develops lipid nanoparticle nucleic acid therapies

Scientist 1 - Preclinical

Translational Research & Bench BiologyUpdated on Nov 15
ContractVancouver, BC, Canada$84k - $95kIn-person

About the Job

Requirements

  • A PhD in Immunology, Pharmaceutical Sciences, or a Life Sciences discipline, and 5 or more years of related scientific experience, or equivalent education and experience.
  • Expert knowledge and experience in a broad range of preclinical methodologies, including use of nanoparticles in experimental in vitro and in vivo systems and development of novel assays and methods to assess nanoparticle efficacy and immunogenicity.
  • Demonstrated leadership in positively leading and mentoring team members.
  • Demonstrated success in managing multiple research projects and budgets.
  • An actively developing track record of innovation and contribution of novel ideas.
  • Strong organizational skills, time management, and ability to prioritize.
  • Strong written and oral communication skills, including respectful, honest, open, and objective communication.
  • Initiative to proactively look for opportunities for oneself, peers, and the company.
  • Ability to learn, adapt, and generate new ideas individually and as a team member.
  • Solution-oriented approach, proactively seeking solutions and presenting assessments and solutions for oneself, peers, and the company.
  • Flexibility in planning ahead, considering a variety of options, and embracing change.
  • Commitment to continuous learning and sharing knowledge, curiosity, and collaboratively finding answers.

Responsibilities

  • Design, execute, analyze, and make recommendations on preclinical research to advance research projects.
  • Mentor and execute ex vivo and in vitro research in support of research goals and plans for internal and external projects.
  • Independently design, execute, and troubleshoot preclinical activities supporting pharmaceutical formulation development and performance testing.
  • Assist with and perform downstream processing of in vivo and in vitro samples for flow cytometry, DNA, RNA, and protein extraction for luminescence and fluorescence measurements, qPCR, and other immunological assays as needed.
  • Follow standard operating procedures and generate and maintain thorough, accurate documentation.
  • Generate, analyze, and tabulate data and results; write and review reports; and make recommendations.
  • Meet established deadlines.
  • Communicate challenges and propose solutions.
  • Lead and support project teamwork.
  • Provide oversight and technical support to other project teams.
  • Prepare and execute multiple internal and external project plans.
  • Prepare and review study reports and technical presentations for internal use and clients.
  • Collaborate and interact with partners and other organizational groups and departments on related projects to develop, characterize, and test formulations.
  • Conduct relevant scientific literature searches.
  • Foster scientific discussions with team members to support critical analysis of literature and generated data.
  • Establish new capabilities based on literature review.
  • Identify novel research opportunities.
  • Assist in writing patent applications and develop patentable ideas.
  • Develop the scientific team through mentoring, supervising, and guiding team members on assigned projects.
  • Support and encourage the personal and professional growth and development of team members.

About the Company

Nanovation Therapeutics

Develops lipid nanoparticle nucleic acid therapies

NanoVation Therapeutics (NTx) develops and delivers nucleic acid therapies using lipid nanoparticle (LNP) platforms. Its LNP formulations are scalable and customizable to target specific tissues, payloads, and administration routes, enabling delivery of mRNA and other nucleic acids. The company differentiates itself with a next-generation LNP platform and a global network of NanoVation GENErators that foster collaboration and faster development, supported by partnerships and licensing. Its goal is to advance genetic medicines so more diseases become manageable or curable by improving delivery efficiency, safety, and durability.

Company size
11-50
Company stage
Grant
Total funding
$300K
Headquarters
Vancouver, Canada
Founded
2020

Recently Posted Jobs

Explore more opportunities at Nanovation Therapeutics

See more jobs